Wellington Management appeared to be the VC, which was created in 1970. The main office of represented VC is situated in the Boston. The company was established in North America in United States.
Besides them, we counted 2 critical employees of this fund in our database.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Internet, Software. Among the most popular portfolio startups of the fund, we may highlight Uber, WeWork, Airbnb. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2018. Deals in the range of more than 100 millions dollars are the general things for fund. This Wellington Management works on 12 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 deals per year. Considering the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The average startup value when the investment from Wellington Management is more than 1 billion dollars.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Wellington Management, startups are often financed by New Enterprise Associates, Greylock Partners, General Catalyst. The meaningful sponsors for the fund in investment in the same round are Tiger Global Management, RA Capital Management, IVP (Institutional Venture Partners). In the next rounds fund is usually obtained by EquityZen, SoftBank Investment Advisers, SharesPost Investment Management.
Related Funds
Funds with similar focus
| Fund Name | Location |
| ACE Management | France, Ile-de-France, Paris |
| Aitken Investments | - |
| Bayview Capital | Minnesota, United States, Wayzata |
| GFB ONLUS | - |
| Istituto zooprofilattico sperimentale dell'Abruzzo | - |
| Loversoul | - |
| Nan Fung Life Sciences | California, San Francisco, United States |
| Palomar Ventures | California, Ladera Ranch, United States |
| The Futura Corp | British Columbia, Canada, Vancouver |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Binkey | $3M | 14 Dec 2023 | Washington, District of Columbia, United States | ||
Avalyn Pharma | $175M | 27 Sep 2023 | Seattle, Washington, United States | ||
MUSINSA | $190M | 19 Jul 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Orennia | $25M | 11 Jul 2023 | Calgary, Canada | ||
Caraway | $16M | 20 Jun 2023 | New York, New York, United States | ||
Upstream Bio | $200M | 08 Jun 2023 | Waltham, Massachusetts, United States | ||
Alkeus Pharmaceuticals | $150M | 05 Jun 2023 | Boston, Massachusetts, United States | ||
Boundless Bio | $100M | 16 May 2023 | San Diego, California, United States |
– Arcadia, the climate-crisis-fighting technology company unlocking nationwide access to energy data and renewables, announced a $100m Series D funding round led by Tiger Global Management and the Drawdown Fund with participation from new investors Wellington Management, Reimagined Ventures (the family office of Alec Litowitz, founder of Magnetar Capital), Camber Creek, MCJ Collective, and existing investors Energy Impact Partners, G2 Venture Partners, Inclusive Capital, and BoxGroup.
– Combined with the Company’s previously undisclosed $21m Series C-1 in December 2020, Arcadia has now raised $180m in total funding.
– The new round of capital will be used to accelerate Arcadia’s technology roadmap, expanding product capabilities across new verticals including electric vehicles and distributed energy resources to catalyze innovation in the sector, making renewables accessible and affordable for all.
– Trove is a Brisbane CA-based branded recommerce company.
– Company raised $77.5M in Series D funding.
– The round was led by G2 Venture Partners with participation from Bank of Montreal, Capital One Ventures, Commerce Ventures and Wellington Management.
– The new investment will be used to expand its roster of brand partners, strengthen its technology and logistics infrastructure, enter the luxury vertical, and service a new customer audience in Europe.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Binkey | $3M | 14 Dec 2023 | Washington, District of Columbia, United States | ||
Avalyn Pharma | $175M | 27 Sep 2023 | Seattle, Washington, United States | ||
MUSINSA | $190M | 19 Jul 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Orennia | $25M | 11 Jul 2023 | Calgary, Canada | ||
Caraway | $16M | 20 Jun 2023 | New York, New York, United States | ||
Upstream Bio | $200M | 08 Jun 2023 | Waltham, Massachusetts, United States | ||
Alkeus Pharmaceuticals | $150M | 05 Jun 2023 | Boston, Massachusetts, United States | ||
Boundless Bio | $100M | 16 May 2023 | San Diego, California, United States |
